Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 46 | $3,417,712 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 23 Aug 2023 | Sale | 223 | 844 | 188,212 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 31 | 826.36 | 25,617 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 243 | 825.37 | 200,565 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 157 | 824.54 | 129,453 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 181 | 823.6 | 149,072 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 128 | 822.67 | 105,302 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 142 | 821.4 | 116,639 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 115 | 820.85 | 94,398 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 10 | 818.81 | 8,188 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 7 | 830.01 | 5,810 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 4 | 829.16 | 3,317 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 13 | 825.59 | 10,733 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 4 | 824.3 | 3,297 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 18 | 822.57 | 14,806 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 48 | 821.39 | 39,427 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 50 | 820.46 | 41,023 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 39 | 819.47 | 31,959 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 28 | 797.43 | 22,328 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 18 | 796.43 | 14,336 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 59 | 795.41 | 46,929 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 99 | 794.61 | 78,666 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 2 | 793.33 | 1,587 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 3 | 791 | 2,373 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 10 | 790.41 | 7,904 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 49 | 789.05 | 38,663 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 99 | 788.62 | 78,073 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 58 | 787.47 | 45,673 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 85 | 786.45 | 66,848 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 78 | 785.88 | 61,299 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 113 | 784.27 | 88,623 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 51 | 783.05 | 39,936 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 03 Feb 2023 | Sale | 739 | 764.5 | 564,966 | D |
02 Dec 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 02 Dec 2022 | Sale | 12 | 760.19 | 9,122 | D |
02 Dec 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 02 Dec 2022 | Sale | 16 | 759.9 | 12,158 | D |
02 Dec 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 02 Dec 2022 | Sale | 582 | 756.5 | 440,283 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 19 | 763.1 | 14,499 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 17 | 762.92 | 12,970 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 119 | 761.36 | 90,602 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 13 | 760.9 | 9,892 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 70 | 759.39 | 53,157 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 42 | 758.2 | 31,844 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 81 | 755.46 | 61,192 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 80 | 754.39 | 60,351 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 40 | 753.23 | 30,129 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 1 | 750 | 750 | D |
18 Oct 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 17 Oct 2022 | Sale | 358 | 739.5 | 264,741 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)